Financials · Reinsurance · US stock · price as of 16 Oct 2026
Key indicators
Price
$389.10
52-week range
$295.27 – $398.90
Market cap
$15.1B
P/E (trailing)
8.2×
Dividend yield
2.1%
Revenue (last 12 months)
$16.8B
Revenue growth (3y a year)
13.2%
Price / book
1.0×
Return on equity
12.4%
Fair value
Blended fair value$571.16 book-value models
Versus priceUndervalued+47% to fair value
Excess-return model (banks, insurers)
$461.45
Price / book vs return on equity
$735.73
Model uncertainty
Medium
X-Ray Score
65/ 100 · Medium confidence · ahead of 92% of sector peers
Valuation92
Growth52
Profitability41
Financial health73
Dividends67
Five-year price chart navy: price · brown: 200-day average · blue band: fair value range
Executive summary
Everest Group is a global reinsurance and insurance company. It sells reinsurance cover to other insurers, helping them manage large and unpredictable losses from events such as storms, earthquakes and liability claims, and it also writes primary insurance directly. Revenue comes mainly from premiums charged for this risk transfer, together with investment income earned on the funds it holds until claims are paid. Results depend heavily on underwriting discipline and on the frequency of major catastrophe events.
Revenue over the last twelve months was $16.8 billion, with growth of 13.2% a year over three years. The operating margin stands at 13.4%. The return on invested capital is shown as 13%. Shareholders receive a dividend yielding 2.1%. These numbers describe past results and current financial position, and they are shown for reference only.
StocksXray gives Everest Group, Ltd. an X-Ray Score of 65 out of 100 (medium confidence), ahead of 92% of the S&P 500 stocks in its sector. Its strongest lens is valuation (92) and its weakest is profitability (41).
Our fair value blend is $571.16. At $389.10 the stock trades 32% below that blend, so the label is "Undervalued" with medium model uncertainty. Fair value is a range, not a price target.
XStocksXray
Everest Group, Ltd. (EG)
Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months
FY2021
FY2022
FY2023
FY2024
FY2025
Now
Price
$247.28
$305.97
$332.56
$347.82
$333.43
$389.10
Market cap
$9.7B
$11.9B
$13.7B
$14.9B
$13.9B
$15.1B
P/E
7.1×
20.1×
5.5×
10.9×
8.8×
8.2×
Price / book
1.0×
1.4×
1.0×
1.1×
0.9×
1.0×
Dividend yield
2.51%
2.12%
2.04%
2.23%
2.40%
2.06%
Fundamentals checklist ● 4 Good · ● 1 Average · ● 2 Bad · each check graded against the sector
Risk models
Piotroski F-Score8 of 9Good
Growth
EPS growth (3y)35.5%Good
Revenue growth (3y)13.2%Good
Growth consistency70%Bad
Valuation
Fair value vs price1.5×Good
Profitability
Return on invested capital13.4%Average
Operating margin13.4%Bad
XStocksXray
Everest Group, Ltd. (EG)
Financials US$ millions, from SEC filings; last column is the last twelve months
Income statement
FY21
FY22
FY23
FY24
FY25
LTM
Revenue
11,866
12,060
14,587
17,281
17,496
16,771
Net income
1,379
597
2,517
1,373
1,591
1,913
Diluted EPS ($)
34.62
15.19
60.19
31.78
37.80
47.35
Net margin
11.6%
5.0%
17.3%
7.9%
9.1%
11.4%
Balance sheet
FY21
FY22
FY23
FY24
FY25
LTM
Total assets
38,185
39,966
49,399
56,341
62,514
62,167
Cash
1,441
1,398
1,437
1,549
1,318
1,117
Total debt
–
–
–
–
–
–
Equity
10,139
8,441
13,202
13,875
15,461
15,430
Dividend per share ($)
6.20
6.50
6.80
7.75
8.00
8.00
Revenue and net income US$ billions: navy revenue, teal net income
Margins blue gross, teal operating, brown net
Latest quarters
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue ($M)
4,263
4,491
4,319
4,423
4,068
3,961
Growth vs a year earlier
+3.1%
+6.2%
+0.8%
−4.6%
−4.6%
−11.8%
Net income ($M)
210
680
255
446
653
559
Diluted EPS ($)
4.90
16.10
6.09
–
16.21
14.22
XStocksXray
Everest Group, Ltd. (EG)
Peers in Reinsurance
Company
X-Ray
EG · Everest Group, Ltd.
65
Market Compass outlook for Financials: Favourable (72/100). It blends regime history, macro sensitivity, momentum and valuation.
Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.